|
STICKY:
Healio/HCV Updates
(
1 2 3
)
(Preview)
http://www.healio.com/infectious-disease/hepatitis-c
|
Tig
|
107
|
14162
|
|
|
|
|
STICKY:
HCV - Hep C Defined
(Preview)
I found this article, two years old, but very informative, and current. We continue to have many guests checking in daily, and I hope this will help provide better understanding to them. Hepatitis C Defined
|
Tig
|
0
|
180
|
|
|
|
|
STICKY:
AASLD & IDSA HCV Treatment Updates/Guidelines
(Preview)
The latest recommendations and an interactive website for inquisitive minds! Updated information available. HCV Guidelines
|
Tig
|
1
|
859
|
|
|
|
|
STICKY:
HCV News Updates
(Preview)
There seems to be a lot of articles available now, so I thought a section to add miscellaneous items we find across the web, might be useful. Feel free to add information that is accurate and helpful for those seeking it. Always credit the source. Thanks! Drugs. com Hep C News
|
Tig
|
0
|
976
|
|
|
|
|
STICKY:
HCV Advocate Monthly Report
(Preview)
Current reports from the HCV Advocate Drug Pipeline and Monthly report. Good stuff! August 1, 2017 Aug 2017 Eblast Newsletter
|
Tig
|
21
|
4976
|
|
|
|
|
STICKY:
Technivie Monograph
(closed)
(Preview)
Technivie Monograph Manufacturer has discontinued this treatment drug.
|
Tig
|
0
|
3210
|
|
|
|
|
STICKY:
Daklinza Monograph
(closed)
(Preview)
Daklinza Monograph (Manufacturers detailed package insert)
|
Tig
|
0
|
3160
|
|
|
|
|
STICKY:
MAVIRET/MAVYRET Monograph (glecaprevir/pibrentasvir)
(closed)
(Preview)
Maviret/Mavyret Monograph
|
Tig
|
0
|
4341
|
|
|
|
|
STICKY:
Zepatier Monograph
(closed)
(Preview)
Zepatier Monograph (Manufacturers detailed package insert)
|
Tig
|
0
|
3108
|
|
|
|
|
STICKY:
Viekira Pak - Viekira XR Monograph(s)
(closed)
(Preview)
Abbvie Pharmaceutical has improved the original Viekira Pak formulation and has included the timed release product called Viekira XR. That description and the original formulation of Viekira Pak follow. (Manufacturers detailed package insert) Viekira XR Monograph Viekira Pak Monograph
|
Tig
|
0
|
3326
|
|
|
|
|
STICKY:
Epclusa Monograph
(closed)
(Preview)
Detailed manufacturers information (package insert) on Epclusa Epclusa Monograph
|
Tig
|
0
|
3154
|
|
|
|
|
STICKY:
Vosevi Monograph
(closed)
(Preview)
VOSEVI Monograph (Manufacturers detailed package insert)
|
Tig
|
0
|
3801
|
|
|
|
|
STICKY:
Hepatitis C Medication VA Review & Updates
(closed)
(Preview)
How is hepatitis C treated?Hepatitis C virus is treated with all-oral medications. These pills, called antiviral medications, are usually taken once per day. These antiviral medications are extremely good at attacking the virus and preventing it from multiplying.Antiviral medications wer...
|
Tig
|
0
|
3292
|
|
|
|
|
STICKY:
HARVONI Monograph
(closed)
(Preview)
Harvoni Monograph -Manufacturers Insert
|
Tig
|
0
|
5023
|
|
|
|
How Iceland Slashed Hepatitis C Infections
(Preview)
Interesting article from Medpage Today. Treatment as Prevention
|
Tig
|
0
|
38
|
|
|
|
|
American Liver Foundation Newsletter
(Preview)
http://www.liverfoundation.org/education/liverlowd...
|
Tig
|
2
|
1081
|
|
|
|
|
Hepatitis C in Appalachia
(Preview)
Please take a moment and read this article. It's not too long and is really informative. We have had so many issues facing us this last year, and Hep C hasn't been discussed much. Let's keep that communication flowing. The need for current information and advocacy is expanding, especially in Appalac...
|
Tig
|
0
|
153
|
|
|
|
|
Viral Hepatitis National Strategic Plan: 2021–2025
(Preview)
Here's the plan! Lengthy but full of current information. Viral Hepatitis National Strategic Plan: 2021–2025
|
Tig
|
0
|
245
|
|
|
|
|
Hepatitis C and Covid-19
(Preview)
Hepatitis C infections tripled in the U.S. from 2009-18, prompting the Centers for Disease Control and Prevention (CDC) to update screening recommendations that include all adults and pregnant women. This increase is especially concerning, since people who have existing chronic medical issu...
|
Tig
|
0
|
362
|
|
|
|
|
Newest Treatments for Hepatitis C
(Preview)
Here's a recent article from Healthline on current protocols and updates on treatment. Hepatitis C (hep C) infection used to be a lifelong condition for most people. Only about 15 to 25 percent Trusted Source of people clear the hepatitis C virus (HCV) from their body without treatment. For everyon...
|
Tig
|
1
|
428
|
|
|
|
|
Dramatic Increases in HCV 2020
(Preview)
This is disturbing information. We as a subset of society, HCV Warriors, have fought so hard to educate and help people to defeat the Dragon, only to be kicked in the teeth again. Do your best to stay healthy, stay informed and educate/advocate for continued research into killing this beast. Our desi...
|
Tig
|
0
|
324
|
|
|
|
|
CDC Recommendations
(Preview)
This is a worthwhile article. It’s just a summary, but maps things pretty well. Check it out, I bet it brings back some memories, for most anyway... CDC 2020
|
Tig
|
0
|
482
|
|
|
|
|
HepVu Updates
(Preview)
Hello, I've been receiving these articles from HepVu and wanted to pass along their website. It's a very informative website and organization. I recommend you take a moment and look around the information provided. The infection rate by state is an interesting map. We've got a long way to go before w...
|
Tig
|
0
|
657
|
|
|
|
|
Hep A Food Warning Dec.2019
(Preview)
I received notice of a Hepatitis A outbreak in the USA, resulting from blackberries. Please read! Hep A Warning
|
Tig
|
0
|
693
|
|
|
|
|
What is Daclatasvir used for?
(Preview)
Uses. Daclatasvir is used with another antiviral medication (sofosbuvir) to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. Daclatasvir should never be used without sofosbuvir. Daclatasvir and sofosbuvir may also be used with another antiviral medica...
|
emilyjones
|
0
|
610
|
|
|
|
|
New Contenders?? NS5A Ruzasvir and NS5B MK-3682
(Preview)
Another "new?" NS5A - "Ruzasvir" - Info from drug study discussed at recent Nov 2106 Boston Meeting.We have heard a lot about Zepatier (elbasvir/ grazoprevir) a NS5A and a NS3/4A respectively (given with or without riba, and sometimes with sof), but I (personally) did not know about this (new to m...
|
Canuck
|
8
|
3287
|
|
|
|
|
GT3's - (and more so, maybe "certain" GT3 sub-types) - perhaps why we have most often been considered "hard to treat"
(Preview)
Published in GastroenterologyJournal Scan / Research · May 20, 2019Resistance Analysis of Genotype 3 HCV Indicates Subtypes Inherently Resistant to Nonstructural Protein 5A InhibitorsHepatology (Baltimore, Md.)TAKE-HOME MESSAGEThis is an interesting study wherein the authors eva...
|
Canuck
|
2
|
1018
|
|
|
|
|
Up-surge of Hep A in California
(Preview)
California health officials battle state's largest hepatitis A outbreak in 2 decadesHelio - July 21, 2017The California Department of Public Health is working with local health officials in San Diego and Santa Cruz counties to contain the state's largest hepatitis A outbreak in 2 decades.As of J...
|
Canuck
|
36
|
5204
|
|
|
|
|
HCC Detection - Using AFP, AFP-L3 and DCP
(Preview)
We have discussed the use of AFP's (many times, all over this site) but of late in particular about how an AFP may be used to possibly herald other kinds of cancers developing, aside from liver cancer, and it lead us to discuss not only the good ole familiar AFP, but the less US-used one, the AFP-L3 (this o...
|
Canuck
|
1
|
668
|
|
|
|
|
Significant A1C reduction after SVR
(Preview)
This is very good news for those of us keeping an eye on our blood glucose levels! SVR brings improvements in areas we might not realize. It takes time to see some of these changes, but knowing it happens, is good news for all! A1C Reductions
|
Tig
|
1
|
893
|
|
|
